BIOMAT Database Logo BIOMAT Database Logo

Effects of supplementation with tocotrienol-rich fraction on immune response to tetanus toxoid immunization in normal healthy volunteers. 2011

D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
Malaysian Palm Oil Board, Selangor, Malaysia.

OBJECTIVE Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers. METHODS In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly. RESULTS The results from the clinical trial showed that TRF supplementation significantly increased the total vitamin E level in the plasma of the TRF-supplemented volunteers compared with the placebo group, indicating overall compliance. Volunteers supplemented with TRF showed a significantly (P < 0.05) enhanced production of interferon-γ and interleukin (IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. Volunteers from the TRF group produced significantly (P < 0.05) lower amounts of IL-6 compared with the placebo group. Anti-TT IgG production was also significantly (P < 0.05) augmented in the TRF-supplemented group compared with the placebo group. CONCLUSIONS We conclude that TRF has immunostimulatory effects and potential clinical benefits to enhance immune response to vaccines.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies

Related Publications

D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
The foetal immune response to maternal tetanus toxoid immunization.
February 1993, The Journal of the Association of Physicians of India,
D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
Serological response to immunization with tetanus toxoid.
April 2000, Bangladesh Medical Research Council bulletin,
D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
Efficient tetanus toxoid immunization on vitamin D supplementation.
March 2011, European journal of clinical nutrition,
D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
Daily supplementation of tocotrienol-rich fraction or alpha-tocopherol did not induce immunomodulatory changes in healthy human volunteers.
March 2009, The British journal of nutrition,
D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
Attenuated immune response to tetanus toxoid in young healthy men protected against tetanus.
October 2005, Vaccine,
D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
Immunization with Tetanus Toxoid: The Recall Response.
May 1940, The Yale journal of biology and medicine,
D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
Comparing the effects of vitamin E tocotrienol-rich fraction supplementation and α-tocopherol supplementation on gene expression in healthy older adults.
March 2019, Clinics (Sao Paulo, Brazil),
D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
Effects of Aging and Tocotrienol-Rich Fraction Supplementation on Brain Arginine Metabolism in Rats.
January 2017, Oxidative medicine and cellular longevity,
D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
Comparing palm oil tocotrienol rich fraction with α-tocopherol supplementation on oxidative stress in healthy older adults.
October 2017, Clinical nutrition ESPEN,
D Mahalingam, and A K Radhakrishnan, and Z Amom, and N Ibrahim, and K Nesaretnam
[Tetanus and immunization with tetanus toxoid].
August 1956, Minerva medica,
Copied contents to your clipboard!